Eric Loumeau

2018

In 2018, Eric Loumeau earned a total compensation of $2.2M as General Counsel at ANAPTYSBIO.

Compensation breakdown

Non-Equity Incentive Plan$54,763
Option Awards$1,961,388
Salary$148,106
Other$774
Total$2,165,031

Loumeau received $2M in option awards, accounting for 91% of the total pay in 2018.

Loumeau also received $54.8K in non-equity incentive plan, $148.1K in salary and $774 in other compensation.

Rankings

In 2018, Eric Loumeau's compensation ranked 5,315th out of 14,244 executives tracked by ExecPay. In other words, Loumeau earned more than 62.7% of executives.

ClassificationRankingPercentile
All
5,315
out of 14,244
63rd
Division
Manufacturing
2,008
out of 5,765
65th
Major group
Chemicals And Allied Products
735
out of 2,128
66th
Industry group
Drugs
615
out of 1,817
66th
Industry
Pharmaceutical Preparations
475
out of 1,391
66th
Source: SEC filing on April 26, 2019.

Loumeau's colleagues

We found three more compensation records of executives who worked with Eric Loumeau at ANAPTYSBIO in 2018.

2018

Hamza Suria

ANAPTYSBIO

Chief Executive Officer

2018

Marco Londei

ANAPTYSBIO

Chief Medical Officer

2018

Dominic Piscitelli

ANAPTYSBIO

Chief Financial Officer

News

In-depth

You may also like